Daniel Wachtlin

机构：Boehringer Ingelheim (Germany)

发表论文 59 篇 · 总被引 1901 次 · h-index 20

代表论文

Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis (2025 · New England Journal of Medicine · 被引 225)
Safety and survival data in patients with idiopathic pulmonary fibrosis treated with nintedanib: pooled data from six clinical trials (2019 · BMJ Open Respiratory Research · 被引 213)
Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: A double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme (2014 · European Journal of Cancer · 被引 137)
Neurofeedback of Slow Cortical Potentials in Children with Attention-Deficit/Hyperactivity Disorder: A Multicenter Randomized Trial Controlling for Unspecific Effects (2017 · Frontiers in Human Neuroscience · 被引 125)
An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer (2011 · European Journal of Cancer · 被引 89)
Statin Therapy and Outcomes in Trials of Nintedanib in Idiopathic Pulmonary Fibrosis (2018 · Respiration · 被引 56)